DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma. - Johnstone CN; Osellame LD; Cao Z; McDonald AF; Rigopoulos A; Burvenich IJG; Wichmann CW; Guo N; Ivashkevich AN; Wheatcroft MP; Yan EB; Zimmermann A; et al. (Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025)